This test is most useful if any of these apply to you.
Most blood panels tell you about cholesterol, sugar, and inflammation. None of them tell you anything about dopamine, the chemical your brain uses to drive motivation, focus, and movement. HVA (homovanillic acid) in urine is one of the few accessible windows into that system.
This is an exploratory marker, not a clinical verdict. It is most strongly validated in pediatric cancer screening, and early research connects urinary HVA to gut dysbiosis and work-related stress in adults. The evidence for urinary HVA in Parkinson's disease is very preliminary, and the much stronger Parkinson's literature involves cerebrospinal fluid HVA, not urine. A single number is not diagnostic.
HVA (homovanillic acid) is the end product your body makes when it breaks down dopamine. Dopamine is built from the amino acid tyrosine, then taken apart by two enzymes (monoamine oxidase and catechol-O-methyltransferase) and excreted through the kidneys. The amount in your urine reflects how much dopamine your body has been producing and metabolizing.
Urinary HVA does not come only from your brain. About half of HVA produced in the body is eliminated by mechanisms other than kidney excretion, and only a small fraction of total body HVA (around 12%) originates from the brain. The rest reflects contributions from sympathetic nerves, the adrenal glands, the mesenteric system, the gut microbiome, and possibly diet. That makes it a whole-body signal of dopamine metabolism, not a pure measure of brain dopamine.
The most established clinical use of urinary HVA is in detecting neuroblastoma, a rare childhood cancer of the sympathetic nerve system. Tumors that secrete catecholamines flood the body with dopamine and its breakdown products, leaving a fingerprint in urine. This use is overwhelmingly pediatric, but it sets the foundation for what an abnormally high reading can mean biologically.
In a three-year series of 408 patients, urinary HVA combined with vanillylmandelic acid (VMA) caught most neuroblastoma cases, with more than 60% of patients showing levels more than twice the upper limit of normal. That particular cohort had no false positives, though other studies report specificity closer to 92% for the HVA plus VMA combination. Pairing HVA with VMA detects about 84 to 85 of every 100 cases. Adding broader catecholamine panels (dopamine, normetanephrine, 3-methoxytyramine) pushes sensitivity to roughly 95 of every 100. A small minority of tumors still slip past these markers.
Parkinson's disease is fundamentally a disorder of dopamine-producing brain cells dying off. The strongest evidence linking HVA to Parkinson's comes from cerebrospinal fluid measurements, where HVA correlates with motor impairment and dopamine transporter imaging. Urinary HVA is a much weaker signal. In a pilot study of 40 Parkinson's patients on levodopa, urinary HVA tracked dopamine metabolism during therapy and clustered alongside gut-microbiota-linked metabolites. This is preliminary research, not a validated use.
Urinary HVA is not a diagnostic test for Parkinson's, and a normal reading does not rule it out. It has not been validated as a screening or risk-assessment tool for presymptomatic disease. Its main role in this context is research.
The gut and the brain share neurotransmitter chemistry. In a study of 60 adults with functional constipation, urinary HVA was higher than in controls, and the ratio of HVA to 5-HIAA (a serotonin breakdown product) correlated with both the severity of gut symptoms and signs of microbial imbalance. The pattern suggests that when dopamine and serotonin signaling in the gut go out of balance, urinary HVA shifts in measurable ways.
This finding comes from a single study and is correlational, not diagnostic. If your standard GI workup is unremarkable but symptoms persist, this is an angle worth discussing with a clinician, but it is not a substitute for established gastroenterology testing.
In a study of 100 workers, those classified as high-stress had lower urinary HVA and dopamine than low-stress peers, and the marker contributed to a composite stress index. The interpretation is that chronic stress can blunt the dopamine system's normal turnover. The study was small and cross-sectional, so do not read a single reading as a verdict on your mental health.
The relationship between stress and dopamine is bidirectional and complex. Acute stress can increase dopamine turnover and raise plasma HVA, while chronic stress may blunt it. Case research on sexually abused girls (21 participants) found higher urinary HVA and other catecholamine metabolites, interpreted as elevated nervous-system activity. These data points illustrate the broader principle: urinary HVA bends in both directions depending on whether your dopamine system is overdriven or worn down.
It can feel contradictory that urinary HVA can be high in one condition and low in another. The reason is that this is not a simple good-number, bad-number marker. It is a phenotype indicator. High HVA can reflect a catecholamine-secreting tumor, active levodopa therapy, or a stressed gut. Low HVA can reflect chronic stress, central dopamine depletion, or simply normal individual variation. The clinical meaning depends entirely on what you are looking for and what else is happening in your body.
Urinary HVA varies day to day with diet, stress, sleep, and timing of collection. A single value gives you a snapshot of one moment in your dopamine metabolism. There is no established retesting cadence for asymptomatic adults, and routine wellness monitoring of urinary HVA is not part of any clinical guideline. If you and your clinician decide repeat testing makes sense in your situation, the trajectory may carry more information than any single number.
Several things can throw off a single reading without saying anything about your underlying biology:
Caffeine, nicotine, and lorazepam did not significantly alter urinary HVA in one small study, so those common exposures are unlikely to distort your reading.
An out-of-pattern HVA reading is a starting point, not an answer. Retest before drawing any conclusion, ideally after a few days of standard diet, no monoamine-rich foods, and avoiding flavonol-rich foods. If the second reading confirms the pattern, the next step depends on your clinical picture.
Pair HVA with a broader catecholamine and metabolite panel if you want to rule out unusual sources of secretion. Add urinary VMA, normetanephrine, and 5-HIAA for a fuller picture of catecholamine and serotonin metabolism. If you have neurological symptoms, a referral to a neurologist familiar with movement disorders adds context that no urine number can supply. If gut symptoms dominate, a gastroenterologist plus a comprehensive stool panel often makes more sense than chasing the HVA reading alone. The marker is most useful as one signal among several, interpreted in light of how you actually feel and what your other labs show.
Evidence-backed interventions that affect your Homovanillic Acid (HVA) level
Homovanillic Acid (HVA) is best interpreted alongside these tests.
Homovanillic Acid (HVA) is included in these pre-built panels.